Episode Details

What unmet needs remain in the diagnosis and treatment of pulmonary fibrosis? In this pulmonary education video, Leah Fingerman, a nurse practitioner at Emory Pulmonary, discusses some of the biggest challenges clinicians face when caring for patients with pulmonary fibrosis and interstitial lung disease (ILD). Many patients are not diagnosed until their disease has already progressed, making earlier detection and intervention a critical unmet need. Leah explores the potential role of improved screening tools, biomarkers, and artificial intelligence (AI) in identifying ILD earlier, predicting disease progression, guiding treatment decisions, monitoring disease activity, and detecting acute exacerbations. She also examines important gaps in pulmonary fibrosis treatment, including the limitations of current antifibrotic therapies, which can slow disease progression but do not reverse existing fibrosis. Looking ahead, new therapies that can repair damaged lung tissue, restore normal lung architecture, and address symptoms could transform care for patients with progressive pulmonary fibrosis. The discussion also highlights the need for better treatments to improve quality of life and reduce the burden of common pulmonary fibrosis symptoms, including chronic cough, shortness of breath (dyspnea), and fatigue. Watch to learn more about the future of pulmonary fibrosis diagnosis, ILD detection, antifibrotic treatment, emerging therapies, and opportunities to improve outcomes for patients living with fibrotic lung disease.

Send us Fan Mail

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA

Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com

Follow us on:

• Instagram @pulmapps 
• Twitter@pulmapp 
• Facebook @association of pulmonary advance practice providers.